Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS–CoV–2 Viral Targets From Clinical Specimens in Near-Patient Settings

RulemakingRuleFDA-2026-N-6238-0001
🔔 Subscribe
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 11, 2026
Comment period
Jun 11, 2026 – ?
Agency
Food and Drug Administration (FDA)
FR Doc
2026-11739
CFR
21 CFR Part 866
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

No comments match.

© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets